Updated:   New York,    London,    Tokyo,    Sofia,
$FTSE 1118.332704     $INDU 1748.065408     $DAX 1825.362704     $SP500 1091.4     AUDUSD 0.913     EURCHF 1.2816     EURGBP 0.8266     EURJPY 106     EURUSD 1.2711     GBPCHF 1.5499     GBPJPY 128.199999     GBPUSD 1.5374     USDBGN 1.5382     USDCAD 1.047199     USDCHF 1.0081     USDJPY 83.39    
Home Products and services Accounts Trading platforms Info centre News and analyses
 
English
Bulgarian
Romanian
Russian
English

 

Currencies
  Symbol Bid Ask
  AUDUSD 0.913 0.9133
  EURCHF 1.2816 1.2819
  EURGBP 0.8266 0.8269
  EURJPY 106 106.03
  EURUSD 1.2711 1.2713
  GBPCHF 1.5499 1.5506
  GBPJPY 128.19 128.27
  GBPUSD 1.5374 1.5378
  USDBGN 1.5382 1.5387
  USDCAD 1.0471 1.0475
  USDCHF 1.0081 1.0084
  USDJPY 83.39 83.42

 

Stock Indices
  Symbol Bid Ask
  $FTSE 1118.3 1122.3
  $INDU 1748.0 1753.0
  $DAX 1825.3 1829.3
  $SP500 1091.4 1092.4

 

Calendar 09.2010 »
Mo Tu We Th Fr Sa Su
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

 

 
 

A proven professional experience:
• Because we enjoy professional experience of more than 10 years in the financial sector and have more than 25 thousand customers;
• Because we offer the full range of investment services for individuals and institutions;
• Because we have participated in some of the most significant deals on the capital market in Bulgaria;
• Because we are a member of the Bulgarian Stock Exchange, the Central Depository and the Investors Compensation Fund.


Our success:
• A market leader by turnover on the Bulgarian Stock Exchange for 2006 and 2007 (banks excluded);
• More than 25 thousand retail customers have chosen the investment services of Bulbrokers related to the Bulgarian Stock Exchange, Forex, stocks & futures order execution and custodian;
• For over 15 years, Bulbrokers has been clearing and holding custody of assets for many individuals and institutions. In 2007, the total amount was more than BGN 1.4 billion.


Our advantages:
• A 24-hour support and a phone dealing desk in Bulgarian and English are provided by Bulbrokers;
• We offer three independent trading platforms - Cobos, Meta Trader, Trader Workstation;
• A professional brokers team guarantees high efficiency in the management of big orders and deals;
• A proven experience in the placement of shares and bonds emissions, IPO and SPO;
• A wide network from foreign institutional partners and financial companies.


Qualitative brokers support:
Our main goal is to satisfy the requirements and the needs of all types of investors – private, professional and institutional. Bulbrokers guarantees equal treatment, confidentiality and high efficiency in the investment operations.

 

 
 
Direct access to important pages »

Home · Products and services · Accounts · Trading platforms · Info centre · News and analyses

Home: About us · Why Bulbrokers · About Financia Group · Management · General Conditions · Order Execution Policy · Careers · Contact us
Products and services: BSE Brokerage · BSE Institutional Services · Fixed incomes · Forex · CFD's · Foreign Stocks and Derivatives · Investment funds · Custodian services
Accounts: Application for new accounts · Managed accounts · Demo account
Trading platforms: COBOS · Bulbrokers System Selector · MetaTrader 4 · Меtа Trader mobile · MetaTrader 4 Multi Terminal · Trader Workstation
Info centre: Download · FX Market · Capital Market · Technical Analysis · Glossary · Feedback · F.A.Q. · Links
News and analyses: Analyses · Regional Analyses · News · Economic Calendar

 
 
 
Latest News »

27.08.2010 The expiration date of CFD on Gold future /GCQ0/ - August 27, 2010

20.07.2010 The expiration date of CFD on Light Sweet Crude Oil /CLQ0/ - July 20, 2010

05.07.2010 US Markets will be closed on July 5th, 2010

 

 

Interesting facts »

 

The world’s largest pharmaceutical company

 

Merck and Co Inc. (New Jersey, USA) is the world’s largest pharmaceutical company. The market price of its assets was 148.8 billion dollars since March 30, 2000 and in 1999 its total sales volume was 32.71 million dollars. This pharmaceutical company makes its own researches; it develops, produces and sells medical products for human medicine, as well as veterinary medicine